ClinicalTrials.Veeva

Menu

Resorbable Magnesium Scaffolds Registry

B

Biotronik

Status

Enrolling

Conditions

Coronary Artery Disease

Treatments

Device: Freesolve
Device: Magmaris

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).

Enrollment

1,106 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • According to the IFU

Exclusion criteria

  • According to the IFU

Trial contacts and locations

13

Loading...

Central trial contact

Marina Gattiglio, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems